Eledon Pharmaceuticals, Inc. Annual Return On Assets in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eledon Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2015 to 2023.
  • Eledon Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -21.4 %, a 86% increase year-over-year.
  • Eledon Pharmaceuticals, Inc. annual Return On Assets for 2023 was -125 %, a 97.7% decline from 2022.
  • Eledon Pharmaceuticals, Inc. annual Return On Assets for 2022 was -63 %, a 230% decline from 2021.
  • Eledon Pharmaceuticals, Inc. annual Return On Assets for 2021 was -19.1 %, a 13.5% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -125 -61.6 -97.7% Jan 1, 2023 Dec 31, 2023
2022 -63 -43.9 -230% Jan 1, 2022 Dec 31, 2022
2021 -19.1 +2.97 +13.5% Jan 1, 2021 Dec 31, 2021
2020 -22 +88.7 +80.1% Jan 1, 2020 Dec 31, 2020
2019 -111 -45.2 -69% Jan 1, 2019 Dec 31, 2019
2018 -65.5 -11.2 -20.7% Jan 1, 2018 Dec 31, 2018
2017 -54.3 -38.4 -242% Jan 1, 2017 Dec 31, 2017
2016 -15.9 +38.8 +71% Jan 1, 2016 Dec 31, 2016
2015 -54.7 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.